Oral Estradiol Cost in Washington 2026

What Does Oral Estradiol Actually Cost in Washington Right Now?

Generic oral estradiol tablets run approximately $15 per month at Washington retail pharmacies in 2026 when paying cash. The brand-level manufacturer list price sits around $40 per month, but virtually no patient who shops generics and uses a discount card pays that figure. Compounded oral estradiol from a licensed 503A pharmacy in Washington can bring the monthly cost to $0 at select partner facilities.

Oral estradiol is FDA-approved for the treatment of moderate-to-severe vasomotor symptoms of menopause and vulvar and vaginal atrophy, as documented in the prescribing information available through the FDA's Drugs@FDA database. [1] The active ingredient is 17-beta estradiol, the same endogenous hormone produced by the ovaries. Because multiple generic manufacturers have been producing estradiol tablets for decades, the market is highly competitive and retail prices have remained low.

Prices vary somewhat by pharmacy chain. GoodRx and similar platforms show a 30-day supply of estradiol 1 mg tablets ranging from roughly $9 to $22 at major Washington chains including Walgreens, Rite Aid, Costco, and Fred Meyer in 2026. A 90-day supply at Costco Pharmacy can drop the per-month equivalent to as low as $7. Using a manufacturer savings card or a third-party discount card (GoodRx Gold, RxSaver, NeedyMeds) consistently brings the price below $20 without any insurance involvement. [2]

The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement confirms that oral estradiol remains one of the most extensively studied estrogen formulations available, with a well-characterized safety and efficacy profile developed over decades of clinical use. [3] That long history of use has translated directly into a mature generic market and downward price pressure.

How Washington Medicaid (Apple Health) Covers Oral Estradiol

Washington Apple Health covers oral estradiol for moderate-to-severe vasomotor symptoms with prior authorization (PA). Without PA approval, the drug is not automatically dispensed under the managed care formularies administered by Molina Healthcare of Washington, Coordinated Care, and other Apple Health contractors.

The PA process for oral estradiol through Apple Health typically requires documentation of the diagnosis (ICD-10 code N95.1 for menopausal and female climacteric states or related codes), a prescribing provider's clinical notes, and confirmation that the patient has not had a contraindicated condition such as a history of estrogen-dependent neoplasia. Washington's Medicaid preferred drug list for 2025-2026 places generic estradiol tablets in a covered tier after PA. Prescribers can submit PA requests electronically through the ProviderOne system or via fax to the relevant managed care organization.

The FDA prescribing label for estradiol tablets carries a boxed warning regarding cardiovascular risk, breast cancer risk, and dementia. [1] Clinicians submitting PA documentation should address these risks directly. The Women's Health Initiative (WHI) trial published in JAMA in 2002 (N=16,608) reported hazard ratios for coronary heart disease of 1.29 (95% CI 1.02 to 1.63) with conjugated equine estrogen plus medroxyprogesterone acetate versus placebo. [4] That finding, while specific to a combined CEE/MPA regimen rather than oral estradiol alone, remains the landmark safety reference that Apple Health PA reviewers and prescribers cite when assessing appropriateness.

Patients enrolled in Apple Health who are also eligible for Medicare (dual-eligible) may find oral estradiol covered under Medicare Part D rather than Medicaid. Part D formulary tiers for generic estradiol vary by plan, but most Tier 1 placements carry a $0 to $5 copay for dual-eligible beneficiaries receiving Low Income Subsidy (LIS). [5]

Which Private Insurance Plans in Washington Cover Oral Estradiol?

Most commercial insurance plans sold in Washington cover generic oral estradiol at Tier 1 or Tier 2, meaning copays of $5 to $30 per 30-day supply. Regence BlueShield of Washington, Premera Blue Cross, Kaiser Permanente Washington, and Molina Healthcare commercial plans all list generic estradiol tablets on their 2025-2026 formularies at preferred generic or generic tiers. [6]

Under the Affordable Care Act, non-grandfathered health plans sold in Washington must cover preventive services rated A or B by the U.S. Preventive Services Task Force (USPSTF) with no cost sharing. [7] The USPSTF recommends against the use of combined estrogen-progestogen therapy for the prevention of chronic conditions in postmenopausal women (Grade D recommendation for prevention), but this is distinct from treatment of symptomatic menopause, which retains Tier 1 or Tier 2 formulary placement under most plans as a treatment-indicated medication. [8]

Short-cycle quantity limits are common. Many Washington plans require a 30-day initial fill before authorizing 90-day supplies. Step therapy (requiring a trial of another agent first) is less commonly applied to oral estradiol than to newer branded drugs, because generic estradiol is already the lowest-cost therapeutic option in its class. Patients who receive a step-therapy denial may appeal by submitting documentation of clinical urgency under Washington State's step-therapy override law (RCW 48.43.835), which requires insurers to grant exceptions within 72 hours for urgent cases.

Is Compounded Oral Estradiol Legal in Washington State?

Compounded oral estradiol is legal in Washington when prepared by a 503A-licensed compounding pharmacy operating under a valid patient-specific prescription. Washington State Department of Health regulates pharmacy compounding under the Uniform Disciplinary Act and aligns with USP Chapter 795 standards for non-sterile preparations. [9]

The FDA distinguishes between 503A pharmacies (patient-specific compounding) and 503B outsourcing facilities (larger-scale production without a specific prescription). Estradiol is not on the FDA's current list of bulk drug substances that may be used in compounding under 503A without a prescription from a licensed prescriber, meaning a valid prescription is always required. [10]

Compounded oral estradiol typically comes as customized-dose capsules, often in doses not commercially available (such as 0.25 mg or 0.5 mg), which some prescribers prefer for patients who require very low starting doses. The cost at partner 503A compounding pharmacies in Washington can be $0 when integrated into a telehealth membership model. Outside of membership arrangements, compounded estradiol capsules at Washington compounding pharmacies typically cost $20 to $60 per month depending on dose, base material, and quantity. [11]

One distinction worth understanding: "bioidentical" is a marketing term, not a regulatory category. The FDA has noted that the term is not recognized in federal law or regulation and does not imply superior safety or efficacy compared to FDA-approved estradiol products. [10] Both compounded and FDA-approved oral estradiol contain 17-beta estradiol; the formulation, excipients, and quality-control testing differ.

How Oral Estradiol Dosing Affects Total Cost

Standard oral estradiol doses studied in clinical trials are 0.5 mg, 1 mg, and 2 mg daily. The REPLENISH trial (NCT01412814, N=1,835) evaluated a combined estradiol/progesterone softgel capsule at multiple doses and found that the 1 mg estradiol component produced statistically significant reductions in moderate-to-severe vasomotor symptom frequency versus placebo at 12 weeks. [12] Similar dose-response findings appear in the Menopause Pharmacology Review published in the journal Menopause, which reports that most symptomatic relief occurs at 1 mg daily, with 2 mg daily offering additional benefit for severe symptoms in a subset of patients. [13]

Higher doses cost more in absolute terms but the difference is small given low per-tablet pricing. A 30-day supply of estradiol 2 mg tablets costs approximately $18 to $25 cash-pay in Washington, versus $9 to $15 for 1 mg tablets. The clinical decision to use 1 mg versus 2 mg should be driven by symptom burden and individual response, not cost differences of this magnitude.

Dose titration over the first 8 to 12 weeks means some patients fill two different strengths during their first three months of therapy. Prescribers should write the initial prescription for a 30-day supply to allow titration before authorizing 90-day refills. [1]

The Cheapest Way to Get Oral Estradiol in Washington

The lowest out-of-pocket path for most Washington residents without Medicaid is a combination of a generic prescription and a GoodRx or RxSaver discount code at a high-volume pharmacy such as Costco, which does not require a membership to use its pharmacy. At Costco Pharmacy in Seattle, Bellevue, and Tacoma, a 90-day supply of estradiol 1 mg (90 tablets) has been priced at approximately $7 to $12 total using discount codes in 2026.

For patients enrolled in Apple Health, obtaining PA approval brings the cost to $0 or a nominal copay of $1 to $3 per fill depending on the managed care plan. Washington state law limits cost-sharing for Medicaid enrollees on preferred generics to minimal amounts. [5]

Telehealth platforms licensed in Washington (including HealthRX) can issue oral estradiol prescriptions electronically to any Washington-licensed retail or compounding pharmacy. The telehealth visit itself has a cost, but for patients who would otherwise pay for an in-person office visit, the net expenditure may be lower, particularly for patients without insurance or with high deductibles.

Manufacturer patient assistance programs for branded estradiol products (such as Estrace by Allergan) require income verification and are typically limited to patients who are uninsured and meet federal poverty level thresholds. Given that generic oral estradiol already costs under $20 per month, these programs are most relevant only if a prescriber determines that a branded product is medically necessary. [14]

Washington-Specific Discount and Assistance Programs for Oral Estradiol

Washington Healthplanfinder (the state ACA exchange) connects residents to subsidized insurance plans, many of which cover generic estradiol at low or no cost-sharing once the deductible is met. For patients who qualify for cost-sharing reduction (CSR) subsidies (household income 100 to 250 percent of the federal poverty level), effective cost-sharing for Tier 1 generics can drop to $0 to $5. [7]

The Washington State Pharmacy Assistance Program (WSPAP), administered by the Washington State Health Care Authority, provides medication assistance for low-income Medicare beneficiaries who do not qualify for federal LIS. Oral estradiol may qualify under WSPAP if it appears on the Medicare Part D formulary of the enrollee's plan. [15]

NeedyMeds.org lists Washington-specific patient assistance programs and free or low-cost clinic resources where uninsured patients can receive prescriptions for oral estradiol at reduced cost. The site aggregates 503A compounding pharmacy discount arrangements, manufacturer coupons, and state programs in a single searchable database. [2]

The Hormone Health Network, a public education resource of the Endocrine Society, provides guidance on finding affordable hormone therapy and connecting with providers who accept sliding-scale fees. [16] For patients in rural Washington counties, federally qualified health centers (FQHCs) operating under the 340B Drug Pricing Program can dispense oral estradiol at significantly reduced prices. The 340B ceiling price for estradiol tablets is substantially below retail, meaning FQHCs in Yakima, Spokane, Wenatchee, and other rural Washington cities may offer the drug at near-zero cost to eligible patients. [17]

Oral Estradiol Safety Data Relevant to Prescribing Decisions in Washington

Prescribers and patients in Washington making cost-related decisions about oral versus non-oral estradiol should understand the pharmacokinetic differences that may affect safety. Oral estradiol undergoes first-pass hepatic metabolism, producing supraphysiologic estrone levels and increasing hepatic synthesis of clotting factors, sex hormone-binding globulin, and triglycerides compared to transdermal delivery. [18]

A cohort study published in BMJ (Vinogradova et al., 2019, N=over 80,000 women) found that oral estradiol was associated with an increased risk of venous thromboembolism (VTE) compared to transdermal estradiol, with an odds ratio of approximately 1.58 (95% CI 1.10 to 2.27) for oral versus transdermal estrogen. [19] This is a clinically relevant distinction for patients with baseline VTE risk factors.

The NAMS 2022 Position Statement notes: "For women with risk factors for venous thrombosis or cardiovascular disease, transdermal estrogen should be considered over oral." [3] That guidance does not mean oral estradiol is contraindicated for most women, but it does mean the route-of-administration choice should factor into shared decision-making beyond cost alone.

For women without elevated VTE risk, oral estradiol at 1 mg daily remains an evidence-based, guideline-supported treatment for menopausal vasomotor symptoms. The drug has been on the market in its current generic form for more than two decades, and its long-term profile is among the most extensively characterized of any hormone therapy formulation. [4]

The HealthRX clinical team uses a three-step access framework for Washington patients considering oral estradiol: first, confirm absence of VTE risk factors that would favor transdermal instead; second, check Apple Health eligibility or commercial formulary tier before the visit to set cost expectations; third, route the electronic prescription to the highest-savings pharmacy (Costco or a partner 503A compounder) at the time of prescribing rather than leaving that step to the patient. This sequence reduces abandoned prescriptions and closes the gap between prescription issuance and first fill.

Oral Estradiol vs. Transdermal Estradiol: Cost Comparison in Washington

Transdermal estradiol patches (0.025 mg to 0.1 mg weekly or twice-weekly) cost approximately $20 to $45 per month cash-pay in Washington for generics, compared to $9 to $22 for oral tablets. Estradiol gel (EstroGel, Divigel) and spray (Evamist) carry higher cash-pay prices, typically $60 to $150 per month, because fewer generic alternatives exist in those delivery formats. [20]

For patients whose primary concern is cost and who lack VTE risk factors, oral tablets remain the lowest-cost option in the estradiol market. Patients with VTE risk factors, those on anticoagulants, or those who have experienced nausea with oral preparations may find transdermal alternatives worth the modest price premium. A prescriber conversation comparing these options takes under five minutes and can meaningfully affect both safety outcomes and adherence.

Insurance formulary placement for transdermal estradiol patches varies. Some Washington commercial plans place generic estradiol patches at Tier 1 alongside oral tablets; others place them at Tier 2, adding $10 to $20 to the monthly copay. Checking the specific plan formulary before prescribing avoids a mismatch between clinical intent and patient cost. [6]